Search

Learn how MSK researchers led the way in the approval of a new mantle cell lymphoma CAR T cell treatment.

… Wednesday, July 31, 2024 Mantle cell lymphoma (MCL) is a rare and sometimes ruthless form of  non-Hodgkin lymphoma . Even when treatment appears to be successful, the cancer often returns and is difficult to cure. A new therapy has been approved by the U.S. Food and Drug Administration (FDA) for these

Memorial Sloan Kettering Cancer Center (MSK) today announced the establishment of The Starr Foundation Program for Discovery Science, a pioneering new initiative made possible by a generous $50 million gift from The Starr Foundation. The program will support the visionary work of scientists at the Sloan Kettering Institute (SKI), the research arm of MSK, by funding foundational laboratory research that will drive the next generation of cancer breakthroughs and ultimately improve the lives of people facing cancer around the world.

… Tuesday, April 19, 2022 Memorial Sloan Kettering Cancer Center (MSK) today announced the establishment of The Starr Foundation Program for Discovery Science, a pioneering new initiative made possible by a generous $50 million gift from The Starr Foundation . The program will support the visionary work

Memorial Sloan Kettering Cancer Center (MSKCC) has opened a new 72,000-square-foot surgical center that was uniquely designed to take advantage of the latest medical technology while enhancing patient safety and efficiency of care.

… Wednesday, June 14, 2006 Memorial Sloan Kettering Cancer Center (MSKCC) has opened a new 72,000-square-foot surgical center that was uniquely designed to take advantage of the latest medical technology while enhancing patient safety and efficiency of care. OR Opening Day “This new facility will enable

Synovial sarcoma is an aggressive cancer primarily affecting children and young adults. A new study gets to the bottom of it.

… Thursday, March 1, 2018 Summary A new study deciphers the molecular cause of an aggressive cancer primarily affecting children and young adults. Researchers at the Sloan Kettering Institute have unraveled how a genetic mutation drives a type of aggressive soft tissue cancer called synovial sarcoma .

Postoperative survival after surgery for spinal metastases has improved over the past 20 years, particularly in patients with kidney, breast, lung, and colon tumors metastatic to the spine.

… Monday, December 14, 2020 Postoperative survival after surgery for spinal metastases has improved over the past 20 years, particularly in patients with kidney, breast, lung, and colon tumors metastatic to the spine, according to a retrospective analysis of patients treated at Memorial Sloan Kettering

Memorial Sloan Kettering Cancer Center (MSK) and Miami Cancer Institute at Baptist Health South Florida announce the beginning of a dynamic and forward-thinking collaboration aimed at improving patient access to the latest and most effective cancer treatment advances and the highest caliber of cancer care. Leaders from both institutions have confirmed the first step in announcing their recently signed agreement for Miami Cancer Institute to join the Memorial Sloan Kettering Cancer Alliance.

… Wednesday, February 10, 2016 Memorial Sloan Kettering Cancer Center (MSK) and Miami Cancer Institute at Baptist Health South Florida announce the beginning of a dynamic and forward-thinking collaboration aimed at improving patient access to the latest and most effective cancer treatment advances and

The summer programs connect high school and medical school students with MSK faculty while offering the opportunity for student-to-student mentorship.

… Thursday, October 6, 2022 At the end of the summer, Memorial Sloan Kettering Cancer Center (MSK) concluded two of its annual research programs for students. Twenty medical school students completed the Summer Pipeline Program and 15 New York City high school students completed the Summer Exposure Program

The Nobel committee this week awarded its Prize in Physiology or Medicine to work focused on cancer, specifically, James P. Allison and Tasuku Honjo for their work on immune checkpoint blockade. Dr. Allison was a member of the Sloan Kettering Institute from 2004 to 2012.

… Thursday, October 4, 2018 The Nobel committee this week awarded its Prize in Physiology or Medicine to work focused on cancer, specifically, James P. Allison and Tasuku Honjo for their work on immune checkpoint blockade. Dr. Allison was a member of the Sloan Kettering Institute from 2004 to 2012. Unlike

OncoKB®, a precision oncology knowledge database developed by MSK researchers and physicians, has received partial recognition status from the US Food and Drug Administration (FDA).

… Thursday, October 7, 2021 OncoKB® , a comprehensive precision oncology knowledge database developed by researchers and physicians at Memorial Sloan Kettering Cancer Center, today received partial recognition status from the US Food and Drug Administration (FDA). It is the first database of somatic variants

New MSK research discovers a new approach that could prevent chemotherapy-related leukemia; shows how monoclonal antibodies can turn neutrophils into cancer killers; helps develop sensitive CAR T cells that target CD70 antigen to destroy cancer cells; and uses single-cell studies to yield new clues about a rare, aggressive pediatric sarcoma.

… Friday, March 20, 2026   New research from Memorial Sloan Kettering Cancer Center (MSK) discovers a new approach that could prevent chemotherapy-related leukemia; shows how monoclonal antibodies can turn neutrophils into cancer killers; helps develop sensitive CAR T cells that target CD70 antigen to